Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant Heart Failure ICD Trials Showing Significant Decrease In Hospital Stay

This article was originally published in The Gray Sheet

Executive Summary

Implantable cardioverter defibrillators (ICDs) are cost-effective in the long run for treating patients with congestive heart failure (CHF), said Guidant VP and Treasurer Todd McKinney asserted at a Dec. 14 ING-Barings health care conference in New York City.

You may also be interested in...



FDA Seeks Applications For 23 Positions On Device Advisory Panels

FDA is seeking "cardiologists with a special interest in congestive heart failure," in addition to interventional cardiologists, electrophysiologists, invasive (vascular) radiologists and vascular and cardiothoracic surgeons to fill three voting positions on its Circulatory System Devices Panel that will open June 30, 2000, according to an Oct. 13 notice appearing in the Federal Register.

Coronary Treatment Guidance Through EP Catheters Supported By Study

Using electrophysiology electrode catheters to induce ventricular tachycardia can better guide physicians in developing treatment options for patients with coronary artery disease and at-risk for sudden cardiac death (SCD) according to the results of a National Heart Lung and Blood Institute-sponsored study released May 13.

Health And Wellness Trademark Review 1 December, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

UsernamePublicRestriction

Register

OM002409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel